Computer-Based Therapy for Mild Cognitive Impairment

Sponsor
Posit Science Corporation (Industry)
Overall Status
Completed
CT.gov ID
NCT00319943
Collaborator
University of California, San Francisco (Other), University of California, Davis (Other), Stanford University (Other)
48
1
21.9
2.2

Study Details

Study Description

Brief Summary

The purpose of this study is to determine the neuropsychological and neurophysiological impacts of a computer-based training program designed to improve the cognitive performance of patients with mild cognitive impairment (MCI).

Condition or Disease Intervention/Treatment Phase
  • Procedure: Computer-based training for Mild Cognitive Impairment (MCI)
Phase 1

Detailed Description

The study is a randomized, double-blind, controlled trial of a computerized, cognitive intervention with three main goals: 1) to assess the magnitude of improvements in memory, language function, and cognitive function following computer training, 2) to investigate the neurophysiological mechanisms underlying such neuropsychological improvements, and 3) to demonstrate the feasibility of using this kind of computer-based therapy in older populations.

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Treatment
Official Title:
Computer-Based Therapy for Mild Cognitive Impairment
Study Start Date :
Sep 1, 2004
Study Completion Date :
Jul 1, 2006

Outcome Measures

Primary Outcome Measures

  1. The study investigates changes in a neuropsychological assessment battery pre-randomization []

  2. and upon the completion of training. []

Secondary Outcome Measures

  1. Early evaluations will be conducted from brain imaging; specifically, date []

  2. obtained via positron emission tomography (PET), magnetoencephalography (MEG), []

  3. electroencephalography (EEG), and functional magnetic resonance imaging (fMRI) []

  4. studies. []

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

1)65 - 90 years of age 2)Meet definition for MCI including complaints of cognitive decline as indicated by patient report and/or informant report, and corroborated by clinician judgment and, the absence of dementia, defined as impairment of memory and at least one other domain of cognitive function.

3)Fluency in English 4)Willing to meet the time commitment of the study

-

Exclusion Criteria:
  1. Clinically significant cerebrovascular disease

  2. Individuals scheduled to begin acetylcholinesterase inhibitor (AChEI) therapy -

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of California, San Francisco San Francisco California United States 94143

Sponsors and Collaborators

  • Posit Science Corporation
  • University of California, San Francisco
  • University of California, Davis
  • Stanford University

Investigators

  • Principal Investigator: Joel Kramer, PsyD, University of California, San Francisco

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00319943
Other Study ID Numbers:
  • OUT-108-2005
First Posted:
Apr 27, 2006
Last Update Posted:
Apr 27, 2006
Last Verified:
Apr 1, 2006
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 27, 2006